Trial intelligence / Profile preview

Lipid emulsion effects on glucose uptake and mitochondrial function in healthy adults

NL-OMON21580Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Dec 2005
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label trial of Intralipid 10%, Clinoleic and saline (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Peripheral glucose uptake and Mitochondrial respiration rates. Started Dec 2005; status: active, not recruiting.

02

Drugs

Intralipid 10%Clinoleicsaline

Beyond the preview

Go deeper on NL-OMON21580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21580.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call